Public Release: 19-Mar-2018 University of Colorado Anschutz Medical Campus IMAGE: Antonio Jimeno, MD, PhD, and University of Colorado Cancer Center colleagues analyze three tumor samples collected over time from a single patient to show how cancer evolves to resist treatment. Credit: University of Colorado Cancer Center After a biopsy or surgery, doctors often get…
The role of fibronectin in BRAF-mutant thyroid cancer treatment medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, PhD, could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene -; a mutation also responsible for some types of melanoma, colorectal cancer, leukemia, lymphoma, and ovarian cancer.